{"AllianceGenome": "19698", "HGNC": "19698", "MIM": "607604", "_id": "169522", "_version": 1, "accession": {"genomic": ["AL354723.17", "CH471071.2", "CP068269.2", "NC_000009.12", "NC_060933.1", "NG_012181.1"], "protein": ["AAI01353.1", "AAI01354.1", "AAL83910.1", "BAG63572.1", "EAW58803.1", "NP_598004.1", "Q8TDN2.1"], "rna": ["AF348983.1", "AK302215.1", "BC101352.1", "BC101353.2", "BQ638061.1", "EL952823.1", "NM_133497.4"], "translation": [{"protein": "AAL83910.1", "rna": "AF348983.1"}, {"protein": "AAI01353.1", "rna": "BC101352.1"}, {"protein": "BAG63572.1", "rna": "AK302215.1"}, {"protein": "NP_598004.1", "rna": "NM_133497.4"}, {"protein": "AAI01354.1", "rna": "BC101353.2"}]}, "alias": ["KV11.1", "Kv8.2", "RCD3B"], "clingen": {"_license": "https://www.clinicalgenome.org/docs/terms-of-use/", "clinical_validity": {"classification": "definitive", "classification_date": "2023-09-07T16:00:00.000Z", "disease_label": "inherited retinal dystrophy", "gcep": "Retina Gene Curation Expert Panel", "moi": "AR", "mondo": "MONDO:0019118", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_b260eab0-c2ff-405c-b720-c223ed6307e9-2023-09-07T160000.000Z", "sop": "SOP10"}}, "ensembl": {"gene": "ENSG00000168263", "protein": "ENSP00000371514", "transcript": "ENST00000382082", "translation": [{"protein": "ENSP00000371514", "rna": "ENST00000382082"}], "type_of_gene": "protein_coding"}, "entrezgene": "169522", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 9.08333274, "exp_mis": 298.8611849, "exp_syn": 147.19334, "lof_z": -3.25936299229958, "mis_z": -2.9181241075886, "mu_lof": 7.2771302783e-07, "mu_mis": 2.6303403579e-05, "mu_syn": 1.29172504148e-05, "n_lof": 19.0, "n_mis": 402.0, "n_syn": 166.0, "p_li": 6.27109599144588e-17, "p_null": 0.999863149739255, "p_rec": 0.000136850260745309, "syn_z": -0.96098815141737}, "bp": 1638, "cds_end": 2729727, "cds_start": 2717739, "n_exons": 2, "nonpsych": {"exp_lof": 8.1800216, "exp_mis": 270.4569491, "exp_syn": 133.1829491, "lof_z": -1.9984631475103, "mis_z": -2.96096903696494, "mu_lof": 7.2771302783e-07, "mu_mis": 2.6303403579e-05, "mu_syn": 1.29172504148e-05, "n_lof": 14.0, "n_mis": 367.0, "n_syn": 147.0, "p_li": 5.60688701401113e-12, "p_null": 0.996069381560721, "p_rec": 0.00393061843367204, "syn_z": -0.753800003011283}, "nontcga": {"exp_lof": 8.35264376, "exp_mis": 274.948288, "exp_syn": 135.41390041, "lof_z": -3.2928931423583, "mis_z": -2.88595404051151, "mu_lof": 7.2771302783e-07, "mu_mis": 2.6303403579e-05, "mu_syn": 1.29172504148e-05, "n_lof": 18.0, "n_mis": 371.0, "n_syn": 153.0, "p_li": 4.0069738873553e-16, "p_null": 0.999787914863306, "p_rec": 0.000212085136694004, "syn_z": -0.956885944184807}, "transcript": "ENST00000382082.3"}, "exons": [{"cdsend": 2729727, "cdsstart": 2717739, "chr": "9", "position": [[2717509, 2719095], [2729445, 2730037]], "strand": 1, "transcript": "NM_133497", "txend": 2730037, "txstart": 2717509}], "exons_hg19": [{"cdsend": 2729727, "cdsstart": 2717739, "chr": "9", "position": [[2717509, 2719095], [2729445, 2730037]], "strand": 1, "transcript": "NM_133497", "txend": 2730037, "txstart": 2717509}], "generif": [{"pubmed": 12060745, "text": "Obligatory heterotetramerization of three previously uncharacterized Kv channel subunits identified in human genome (Kv6.3)(Kv10.1) (Kv11.1)"}, {"pubmed": 16909397, "text": "Mutations mapped to KCNV2 are responsible for cone dystrophy with supernormal rod electoretinogram."}, {"pubmed": 17896311, "text": "KCNV2 mutations account for most if not all cases of cone dystrophy with a supernormal rod electroretinography. We found 1 frameshift, 2 nonsense, 1 non-stop, and 6 missense mutations."}, {"pubmed": 18235024, "text": "The phenotype of cone dystrophy with supernormal rod response is tightly linked with mutations in KCNV2."}, {"pubmed": 18400204, "text": "The three novel truncative mutations are likely to be null mutations leading to loss of function, with no difference in the phenotype presentation."}, {"pubmed": 18708743, "text": "Kv11.1 (ERG1) K+ channels localize in cholesterol and sphingolipid enriched membranes and are modulated by membrane cholesterol."}, {"pubmed": 19952985, "text": "Individuals with mutations in KCNV2 manifest a wide range of macular and autofluorescence abnormalities."}, {"pubmed": 21402906, "text": "Results demonstrate that altered potassium subunit function influences epilepsy susceptibility and implicate Kcnv2 as an epilepsy gene."}, {"pubmed": 21558291, "text": "In KCNV2 retinopathy foveal morphological changes are evident on SD-OCT even in the early stages of disease."}, {"pubmed": 21882291, "text": "In this study, we found that KCNV2 mutations are present in a substantial fraction (2.2-4.3%) of a sample of 367 independent patients with a variety of initial clinical diagnoses of cone malfunctino."}, {"pubmed": 21900228, "text": "For all patients, KCNV2 sequencing revealed one of three homozygous recessive mutations"}, {"pubmed": 21911584, "text": "Early ocular phenotype in siblings with a homozygous p.G461R mutation in the KCNV2 gene presented nystagmus, increased light sensitivity, reduced color discrimination, and relative central scotomas."}, {"pubmed": 23077521, "text": "KCNV2 mutations cause a unique form of retinal disorder illustrating the importance of K(+)-channels for the resting potential, activation and deactivation of photoreceptors, while phototransduction remains unchanged"}, {"pubmed": 23115240, "text": "two pore mutations (W467G and G478R) led to the formation of nonconducting heteromeric Kv2.1/Kv8.2 channels"}, {"pubmed": 23143909, "text": "important finding leading to identification of KCNV2 as a candidate gene for causative mutations was the characteristic pattern of findings on full field ERGs."}, {"pubmed": 23221069, "text": "Central vision parameters progressively worsen in KCNV2 cone dystrophy, structural retinal and lipofuscin accumulation abnormalities are commonly present and macular cone photoreceptor mosaic is markedly disrupted early in the disease."}, {"pubmed": 23725738, "text": "This is the first report of genetic and clinical analysis of cone dystrophy with supernormal rod response in the Israeli population leading to the identification of 4 novel KCNV2 mutations."}, {"pubmed": 23885164, "text": "Compound heterozygosity for the two alleles of KCNV2, p.C177R and p.G461R, in three patients, and homozygosity for complex alleles, p.R27H and p.R206P, in one patient from the consanguineous family, is reported."}, {"pubmed": 24029832, "text": "The 2 mutations identified are novel and thus expand the current knowledge of Retinal Cone Dystrophy 3B genotype-phenotype descriptions in the literature."}, {"pubmed": 28658141, "text": "Pharmacogenetic and case-control study evaluated the role of the variants of KCNA1, KCNA2, and KCNV2 in the susceptibility and drug resistance of genetic generalized epilepsies and revealed no significant association between 8 variants of KCNA1, KCNA2, and KCNV2 genes and risk or drug resistance of genetic generalized epilepsies after a Bonferroni correction for multiple comparisons."}, {"pubmed": 30877594, "text": "Biallelic loss-of-function KCNV2 variants (p.W67X and p.D174GfsX198) were identified as the cause of cone dystrophy with supernormal rod responses (CDSRR). Long-term FF-ERG findings demonstrated there were no ERG changes during 15 years of observation, indicating that there was no evidence of progressive peripheral retinal dysfunction, in spite of worsening macular atrophy."}, {"pubmed": 32441199, "text": "KCNV2 retinopathy: clinical features, molecular genetics and directions for future therapy."}, {"pubmed": 33309813, "text": "KCNV2-Associated Retinopathy: Genetics, Electrophysiology, and Clinical Course-KCNV2 Study Group Report 1."}, {"pubmed": 33706576, "text": "Cone dystrophy with supernormal rod responses: A rare KCNV2 gene variant."}, {"pubmed": 33737031, "text": "KCNV2-Associated Retinopathy: Detailed Retinal Phenotype and Structural Endpoints-KCNV2 Study Group Report 2."}, {"pubmed": 33960280, "text": "A novel KCNV2 mutation in a patient taking hydroxychloroquine associated with cone dystrophy with supernormal rod response."}, {"pubmed": 34063002, "text": "Molecular, Cellular and Functional Changes in the Retinas of Young Adult Mice Lacking the Voltage-Gated K(+) Channel Subunits Kv8.2 and K2.1."}, {"pubmed": 34535971, "text": "Compound heterozygous KCNV2 variants contribute to cone dystrophy with supernormal rod responses in a Chinese family."}, {"pubmed": 36278409, "text": "Initial diagnoses of patients found to be homozygous for a KCNV2 founder mutation on the Arabian Peninsula (c.427G>T; p.Glu143*)."}, {"pubmed": 37852740, "text": "KCNV2-associated retinopathy: genotype-phenotype correlations - KCNV2 study group report 3."}], "genomic_pos": {"chr": "9", "end": 2730037, "ensemblgene": "ENSG00000168263", "start": 2717510, "strand": 1}, "genomic_pos_hg19": {"chr": "9", "end": 2730037, "start": 2717502, "strand": 1}, "go": {"BP": [{"evidence": "IBA", "gocategory": "BP", "id": "GO:0001508", "qualifier": "involved_in", "term": "action potential"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0051260", "qualifier": "involved_in", "term": "protein homooligomerization"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0071805", "qualifier": "involved_in", "term": "potassium ion transmembrane transport"}], "CC": [{"evidence": "TAS", "gocategory": "CC", "id": "GO:0005886", "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0008076", "qualifier": "part_of", "term": "voltage-gated potassium channel complex"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0016020", "qualifier": "is_active_in", "term": "membrane"}], "MF": [{"category": "MF", "evidence": "IBA", "id": "GO:0005249", "qualifier": "enables", "term": "voltage-gated potassium channel activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [32296183, 34535971], "qualifier": "enables", "term": "protein binding"}]}, "homologene": {"genes": [[7955, 567267], [8364, 100498412], [9031, 431642], [9544, 696487], [9598, 473160], [9606, 169522], [9615, 609438], [9913, 784234], [10090, 240595], [10116, 294065]], "id": 26423}, "interpro": [{"desc": "Potassium channel tetramerisation-type BTB domain", "id": "IPR003131", "short_desc": "T1-type_BTB"}, {"desc": "Potassium channel, voltage dependent, Kv", "id": "IPR003968", "short_desc": "K_chnl_volt-dep_Kv"}, {"desc": "Potassium channel, voltage dependent, Kv9", "id": "IPR003971", "short_desc": "K_chnl_volt-dep_Kv9"}, {"desc": "Ion transport domain", "id": "IPR005821", "short_desc": "Ion_trans_dom"}, {"desc": "SKP1/BTB/POZ domain superfamily", "id": "IPR011333", "short_desc": "SKP1/BTB/POZ_sf"}, {"desc": "Voltage-dependent channel domain superfamily", "id": "IPR027359", "short_desc": "Volt_channel_dom_sf"}], "ipi": "IPI00152566", "map_location": "9p24.2", "name": "potassium voltage-gated channel modifier subfamily V member 2", "other_names": ["potassium channel, subfamily V, member 2", "potassium channel, voltage gated modifier subfamily V, member 2", "potassium voltage-gated channel subfamily V member 2", "voltage-gated potassium channel subunit Kv8.2"], "pantherdb": {"HGNC": "19698", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "2670981", "ortholog_type": "LDO", "panther_family": "PTHR11537", "taxid": 10090, "uniprot_kb": "Q8CFS6"}, {"RGD": "1309271", "ortholog_type": "LDO", "panther_family": "PTHR11537", "taxid": 10116, "uniprot_kb": "D3ZZR6"}, {"Ensembl": "ENSGALG00000010173", "ortholog_type": "LDO", "panther_family": "PTHR11537", "taxid": 9031, "uniprot_kb": "F1NC35"}, {"ZFIN": "ZDB-GENE-060526-28", "ortholog_type": "O", "panther_family": "PTHR11537", "taxid": 7955, "uniprot_kb": "A0A2R8QAM9"}, {"ZFIN": "ZDB-GENE-091117-27", "ortholog_type": "LDO", "panther_family": "PTHR11537", "taxid": 7955, "uniprot_kb": "F1Q6N3"}, {"WormBase": "WBGene00001374", "ortholog_type": "O", "panther_family": "PTHR11537", "taxid": 6239, "uniprot_kb": "H2KZQ6"}, {"WormBase": "WBGene00007862", "ortholog_type": "O", "panther_family": "PTHR11537", "taxid": 6239, "uniprot_kb": "J3K003"}, {"WormBase": "WBGene00002242", "ortholog_type": "O", "panther_family": "PTHR11537", "taxid": 6239, "uniprot_kb": "A0A4V0INI0"}, {"Gene_ORFName": "CELE_Y48A6B.6", "ortholog_type": "O", "panther_family": "PTHR11537", "taxid": 6239, "uniprot_kb": "A0A7R9SUL9"}, {"WormBase": "WBGene00012967", "ortholog_type": "O", "panther_family": "PTHR11537", "taxid": 6239, "uniprot_kb": "Q9XXD1"}, {"WormBase": "WBGene00021948", "ortholog_type": "O", "panther_family": "PTHR11537", "taxid": 6239, "uniprot_kb": "U4PLR3"}, {"WormBase": "WBGene00018402", "ortholog_type": "O", "panther_family": "PTHR11537", "taxid": 6239, "uniprot_kb": "Q20381"}, {"FlyBase": "FBgn0262593", "ortholog_type": "O", "panther_family": "PTHR11537", "taxid": 7227, "uniprot_kb": "P17970"}], "uniprot_kb": "Q8TDN2"}, "pathway": {"reactome": [{"id": "R-HSA-112316", "name": "Neuronal System"}, {"id": "R-HSA-1296071", "name": "Potassium Channels"}, {"id": "R-HSA-1296072", "name": "Voltage gated Potassium channels"}]}, "pfam": ["PF00520", "PF02214"], "pharmgkb": "PA134992655", "pharos": {"target_id": 16347, "tdl": "Tclin"}, "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF271279", "relationship": "is"}, {"id": "GNF271280", "relationship": "is"}, {"id": "GNF271281", "relationship": "is"}, {"id": "GNF271282", "relationship": "is"}], "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF087701", "relationship": "is"}, {"id": "GNF087702", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF053415", "relationship": "is"}, {"id": "GNF058183", "relationship": "is"}], "GNF_hs-druggable_siRNA": {"id": "GNF067240", "relationship": "is"}, "GNF_mm+hs-MGC": [{"id": "GNF276895", "relationship": "is"}, {"id": "GNF276905", "relationship": "is"}], "NOVART_hs-genome_siRNA": {"id": "GNF142833", "relationship": "is"}}, "refseq": {"genomic": ["NC_000009.12", "NC_060933.1", "NG_012181.1"], "protein": "NP_598004.1", "rna": "NM_133497.4", "translation": {"protein": "NP_598004.1", "rna": "NM_133497.4"}}, "reporter": {"GNF1H": "gnf1h10418_at", "HG-U133_Plus_2": "217522_at", "HG-U95Av2": "36339_at", "HTA-2_0": "TC09000016.hg.1", "HuEx-1_0": "3160229", "HuGene-1_1": "8154124", "HuGene-2_1": "17083221"}, "summary": "Voltage-gated potassium (Kv) channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. This gene encodes a member of the potassium voltage-gated channel subfamily V. This member is identified as a 'silent subunit', and it does not form homomultimers, but forms heteromultimers with several other subfamily members. Through obligatory heteromerization, it exerts a function-altering effect on other potassium channel subunits. This protein is strongly expressed in pancreas and has a weaker expression in several other tissues. [provided by RefSeq, Jul 2008].", "symbol": "KCNV2", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1426343"}, "unigene": ["Hs.624689", "Hs.622675", "Hs.740173"], "uniprot": {"Swiss-Prot": "Q8TDN2"}, "wikipedia": {"url_stub": "KCNV2"}}